Skip to product information
1 of 1

Shulph Ink

Epigenetic Epidemiology

Epigenetic Epidemiology

💎 Earn 916 Points (£9.16) on this item.

Important: Dispatches within 2 to 4 weeks
Regular price £183.25 GBP
Regular price £219.99 GBP Sale price £183.25 GBP
Sale Sold out
Taxes included. Shipping calculated at checkout.

YOU SAVE £36.74

  • Condition: Brand new
  • UK Delivery times: Usually arrives within 2 - 3 working days
  • UK Shipping: Fee starts at £2.39. Subject to product weight & dimension

Bulk ordering. Want 15 or more copies? Get a personalised quote and bigger discounts. Learn more about bulk orders.

  • More about Epigenetic Epidemiology


This book provides an overview of epigenetic epidemiology and a comprehensive review of the field, covering epigenetic laboratory techniques, age and environmental factors, the epigenetic clock, and health conditions. It is an indispensable resource for researchers working in human epigenetics.

Format: Paperback / softback
Length: 510 pages
Publication date: 16 April 2023
Publisher: Springer Nature Switzerland AG


Epigenetics is a fascinating field that plays a crucial role in shaping our identities and determining our health and disease outcomes. Unlike our genetic inheritance, our epigenome, the collection of chemical modifications on our DNA, is dynamic and can be influenced by various factors throughout our lives. Population-based epidemiologic studies have increasingly incorporated epigenetic components, known as epigenome-wide association studies (EWAS), which have provided valuable insights into the relevance of epigenetic marks, such as DNA methylation, histone modification, and non-coding RNAs, in disease causation.

Written by leading experts in the field, "Epigenetic Epidemiology" offers a comprehensive and up-to-date overview of the basic concepts of epigenetic epidemiology and provides a thorough review of the rapidly evolving field of human epigenetics. The book begins with a comprehensive introduction to the principles of epigenetic epidemiology, discussing challenges in study design, analysis, and interpretation. It then summarizes the latest advances in epigenetic laboratory techniques, the influence of age and environmental factors on shaping the epigenome, the epigenetic clock, and the role of epigenetics in the developmental origins hypothesis.

The final part of the book focuses on epigenetic epidemiology of various health conditions, including imprinting disorders, cancer, infectious diseases, inflammation and rheumatoid arthritis, asthma, metabolic disorders, and vascular disease, as well as neurodevelopmental and psychiatric disorders. Given its scope, "Epigenetic Epidemiology" is an indispensable resource for researchers working in the field of human epigenetics.

Epigenetics is a rapidly evolving field that has the potential to revolutionize our understanding of human health and disease. By studying the chemical modifications on our DNA, researchers can gain insights into the mechanisms underlying various diseases and develop new treatments and interventions. However, there are still many challenges to be addressed, such as identifying the specific epigenetic markers that are associated with different diseases and understanding the biological mechanisms that regulate epigenetic processes.

One of the key challenges in epigenetic research is the need for large-scale studies that can effectively capture the complex interplay between genetics, environment, and disease. This requires collaboration between researchers from different fields and the use of advanced technologies, such as next-generation sequencing and epigenome-wide association studies. Another challenge is the interpretation of epigenetic data, which can be influenced by various factors, including sample size, genetic background, and environmental exposures.

Despite these challenges, epigenetic research has made significant progress in recent years, and there are many exciting developments on the horizon. For example, researchers have identified epigenetic markers that are associated with cancer risk, and they are exploring the potential use of these markers for early detection and personalized treatment. Additionally, epigenetic therapies, such as methylation inhibitors, are being developed to treat certain diseases, and they show promise in improving patient outcomes.

In conclusion, epigenetics is a fascinating field that has the potential to transform our understanding of human health and disease. While there are still many challenges to be addressed, ongoing research and technological advancements are paving the way for new discoveries and breakthroughs. By studying the epigenome, we can gain insights into the mechanisms underlying various diseases and develop new treatments and interventions that can improve the lives of individuals around the world.

Weight: 795g
Dimension: 235 x 155 (mm)
ISBN-13: 9783030944773
Edition number: 2nd ed. 2022

UK and International shipping information

UK Delivery and returns information:

  • Delivery within 2 - 3 days when ordering in the UK.
  • Shipping fee for UK customers from £2.39. Fully tracked shipping service available.
  • Returns policy: Return within 30 days of receipt for full refund.

International deliveries:

Shulph Ink now ships to Australia, Belgium, Canada, France, Germany, Ireland, Italy, India, Luxembourg Saudi Arabia, Singapore, Spain, Netherlands, New Zealand, United Arab Emirates, United States of America.

  • Delivery times: within 5 - 10 days for international orders.
  • Shipping fee: charges vary for overseas orders. Only tracked services are available for most international orders. Some countries have untracked shipping options.
  • Customs charges: If ordering to addresses outside the United Kingdom, you may or may not incur additional customs and duties fees during local delivery.
View full details